BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31059548)

  • 21. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
    Murphy RG; Greenberg ML
    Cancer; 1990 Apr; 65(8):1717-21. PubMed ID: 2317754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone-treated mice.
    Finch ER; Payton MA; Jenkins DA; Cai X; Li L; Karol SE; Relling MV; Janke LJ
    Haematologica; 2021 Aug; 106(8):2095-2101. PubMed ID: 32675219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
    Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K
    J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 25. Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
    Yeo KK; Gaynon PS; Fu CH; Wayne AS; Sun W
    J Pediatr Hematol Oncol; 2016 Jul; 38(5):345-9. PubMed ID: 27352191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Ribeiro RC; Fletcher BD; Kennedy W; Harrison PL; Neel MD; Kaste SC; Sandlund JT; Rubnitz JE; Razzouk BI; Relling MV; Pui CH
    Leukemia; 2001 Jun; 15(6):891-7. PubMed ID: 11417473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
    Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma.
    Chang WJ; Ko YH; Kim SJ; Kim WS
    Leuk Lymphoma; 2014 Sep; 55(9):2196-8. PubMed ID: 24308435
    [No Abstract]   [Full Text] [Related]  

  • 29. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during L-asparaginase therapy.
    Hanada T; Horigome Y; Inudoh M; Takita H
    Eur J Pediatr; 1989 Dec; 149(3):162-3. PubMed ID: 2612502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday.
    Yang L; Boyd K; Kaste SC; Kamdem Kamdem L; Rahija RJ; Relling MV
    J Orthop Res; 2009 Feb; 27(2):169-75. PubMed ID: 18683891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse.
    Hijiya N; Stewart CF; Zhou Y; Campana D; Coustan-Smith E; Rivera GK; Relling MV; Pui CH; Gajjar A
    Cancer; 2008 May; 112(9):1983-91. PubMed ID: 18318429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All dex'ed out with nowhere to go?
    Adamson PC; Barrett JS
    J Clin Oncol; 2008 Apr; 26(12):1917-8. PubMed ID: 18421043
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts.
    Szymanska B; Wilczynska-Kalak U; Kang MH; Liem NL; Carol H; Boehm I; Groepper D; Reynolds CP; Stewart CF; Lock RB
    PLoS One; 2012; 7(3):e33894. PubMed ID: 22479469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal asparaginase therapy.
    Holcenberg J
    J Pediatr Hematol Oncol; 2004 May; 26(5):273-4. PubMed ID: 15111775
    [No Abstract]   [Full Text] [Related]  

  • 36. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
    te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
    Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
    Finch ER; Smith CA; Yang W; Liu Y; Kornegay NM; Panetta JC; Crews KR; Molinelli AR; Cheng C; Pei D; Ramsey LB; Karol SE; Inaba H; Sandlund JT; Metzger M; Evans WE; Jeha S; Pui CH; Relling MV
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28040. PubMed ID: 31612640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.